NHS National Generic Pharmaceuticals - Wave 16a
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £429,887,402 (£515,864,882 inc. VAT) |
|---|---|
| Status | complete |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Procedure | open |
| OCID | ocds-h6vhtk-051c3a |
Awards (164)
This procurement was awarded to 102 suppliers. Values shown are per-award; the notice total is £429,887,402.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord UK Ltd shared | £393,331,872 | 26 Aug 2026 | active |
| Accord UK Ltd shared | £21,026,178 | 26 Aug 2026 | active |
| AFT Pharma UK Limited shared | £393,331,872 | 26 Aug 2026 | active |
| AGB Pharma (UK) Ltd shared | £393,331,872 | 26 Aug 2026 | active |
| Aguettant Limited shared | £393,331,872 | 26 Aug 2026 | active |
| Amarox Limited shared | £393,331,872 | 26 Aug 2026 | active |
| Amarox Limited shared | £21,026,178 | 26 Aug 2026 | active |
| AOP Orphan Limited shared | £393,331,872 | 26 Aug 2026 | active |
| Arcadia Pharma Limited shared | £393,331,872 | 26 Aug 2026 | active |
| ASCEND LABORATORIES (UK) LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| ASCEND LABORATORIES (UK) LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| ASCOT LABORATORIES LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| ASPEN PHARMACARE UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| ASPIRE PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| ASPIRE PHARMA LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| BAXTER HEALTHCARE LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| BAXTER HEALTHCARE LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| B. BRAUN MEDICAL LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| B. BRAUN MEDICAL LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| Biocon Pharma UK Limited shared | £393,331,872 | 26 Aug 2026 | active |
| BOWMED IBISQUS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| BRANCASTER PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| BRANCASTER PHARMA LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| BROWN & BURK UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| BROWN & BURK UK LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| BROWN & BURK UK LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| CELIX PHARMA LTD shared | £393,331,872 | 26 Aug 2026 | active |
| CELIX PHARMA LTD shared | £21,026,178 | 26 Aug 2026 | active |
| CHIESI LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| CIPLA (EU) LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| CIPLA (EU) LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| CLINIGEN HEALTHCARE LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| CLINIGEN HEALTHCARE LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| COLONIS PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| CONSILIENT HEALTH (UK) LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| CRESCENT PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| CRESCENT PHARMA LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| C. S. T. PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| DAY LEWIS MEDICAL LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| DAY LEWIS MEDICAL LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| DESITIN PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| DR REDDY'S LABORATORIES (UK) LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| DR REDDY'S LABORATORIES (UK) LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| DRUGSRUS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| DRUGSRUS LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| ENNOGEN HEALTHCARE INTERNATIONAL LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| ENNOGEN HEALTHCARE INTERNATIONAL LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| ERAMOL (UK) Limited shared | £393,331,872 | 26 Aug 2026 | active |
| ESTEVE PHARMACEUTICALS LTD shared | £393,331,872 | 26 Aug 2026 | active |
| FARMAK PHARMACEUTICALS UK LTD shared | £393,331,872 | 26 Aug 2026 | active |
| FARMAK PHARMACEUTICALS UK LTD shared | £21,026,178 | 26 Aug 2026 | active |
| FARMAK PHARMACEUTICALS UK LTD shared | £15,529,352 | 26 Aug 2026 | active |
| FERRING PHARMACEUTICALS LTD shared | £393,331,872 | 26 Aug 2026 | active |
| FERRING PHARMACEUTICALS LTD shared | £21,026,178 | 26 Aug 2026 | active |
| FLEXIPHARM AUSTRADING LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| FLYNN PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| FLYNN PHARMA LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| FONTUS HEALTH LTD shared | £393,331,872 | 26 Aug 2026 | active |
| FRESENIUS KABI LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| FRESENIUS KABI LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| GALVANY PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| GALVANY PHARMA LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| GENNISIUM PHARMA shared | £393,331,872 | 26 Aug 2026 | active |
| GILEAD SCIENCES LTD shared | £393,331,872 | 26 Aug 2026 | active |
| GLAXOSMITHKLINE UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| GRINDEKS KALCEKS UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| GRINDEKS KALCEKS UK LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| HAMELN PHARMA LTD shared | £393,331,872 | 26 Aug 2026 | active |
| HAMELN PHARMA LTD shared | £21,026,178 | 26 Aug 2026 | active |
| HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| KENT PHARMA UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| KENT PHARMA UK LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| KENT PHARMA UK LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| Lipomed GmbH shared | £393,331,872 | 26 Aug 2026 | active |
| LUNDBECK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| LUNDBECK LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| MACARTHYS LABORATORIES LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| MACARTHYS LABORATORIES LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| MACLEODS PHARMA UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| MACLEODS PHARMA UK LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| MACURE PHARMA UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| MEDAC PHARMA LLP shared | £393,331,872 | 26 Aug 2026 | active |
| Medreich PLC shared | £15,529,352 | 26 Aug 2026 | active |
| MERCURY PHARMACEUTICALS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| MERCURY PHARMACEUTICALS LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| MERCURY PHARMACEUTICALS LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| MILPHARM LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| MILPHARM LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| MILPHARM LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| MORNINGSIDE PHARMACEUTICALS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| MORNINGSIDE PHARMACEUTICALS LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| MSN LABORATORIES EUROPE LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| MSN LABORATORIES EUROPE LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| NECESSITY SUPPLIES LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| NECESSITY SUPPLIES LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| NEON HEALTHCARE LTD shared | £393,331,872 | 26 Aug 2026 | active |
| NEON HEALTHCARE LTD shared | £21,026,178 | 26 Aug 2026 | active |
| NEURAXPHARM UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| NORTHUMBRIA PHARMA THROMBOSIS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| NOVARTIS PHARMACEUTICALS UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| NOVARTIS PHARMACEUTICALS UK LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| NOVUMGEN LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| NOVUMGEN LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| NOVUMGEN LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| Orifarm UK Ltd shared | £393,331,872 | 26 Aug 2026 | active |
| OTSUKA PHARMACEUTICALS (U.K.) LTD. shared | £393,331,872 | 26 Aug 2026 | active |
| PANPHARMA UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| PARI MEDICAL LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| PERENNIAL PHARMA LTD shared | £393,331,872 | 26 Aug 2026 | active |
| PERENNIAL PHARMA LTD shared | £21,026,178 | 26 Aug 2026 | active |
| PFIZER LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| PFIZER LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| Phoenix labs U.C. shared | £393,331,872 | 26 Aug 2026 | active |
| PIERRE FABRE LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| PIRAMAL CRITICAL CARE LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| PROVEPHARM UK LTD shared | £393,331,872 | 26 Aug 2026 | active |
| PROVEPHARM UK LTD shared | £21,026,178 | 26 Aug 2026 | active |
| REIG JOFRE UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| RIDGE PHARMA LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| RIDGE PHARMA LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| ROCHE PRODUCTS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| ROVI BIOTECH LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| RPH PHARMA LTD shared | £393,331,872 | 26 Aug 2026 | active |
| RPH PHARMA LTD shared | £21,026,178 | 26 Aug 2026 | active |
| RPH PHARMA LTD shared | £15,529,352 | 26 Aug 2026 | active |
| SANDOZ LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| SANDOZ LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| SANDOZ LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| SEACROSS PHARMACEUTICALS LTD shared | £393,331,872 | 26 Aug 2026 | active |
| SELECTIVE SUPPLIES LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| SERB LTD shared | £393,331,872 | 26 Aug 2026 | active |
| SERB LTD shared | £21,026,178 | 26 Aug 2026 | active |
| STRIDES PHARMA UK LTD shared | £393,331,872 | 26 Aug 2026 | active |
| STRIDES PHARMA UK LTD shared | £15,529,352 | 26 Aug 2026 | active |
| SUN PHARMA UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| SUN PHARMA UK LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| SUN PHARMA UK LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| SVP PHARMA LTD shared | £393,331,872 | 26 Aug 2026 | active |
| SYNCHRONY PHARMA shared | £393,331,872 | 26 Aug 2026 | active |
| TAKEDA UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| TEVA UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| TEVA UK LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| THEA PHARMACEUTICALS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| THORNTON & ROSS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| THORNTON & ROSS LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| Tillomed Laboratories Ltd shared | £393,331,872 | 26 Aug 2026 | active |
| Tillomed Laboratories Ltd shared | £21,026,178 | 26 Aug 2026 | active |
| TORBAY PHARMACEUTICALS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| TORRENT PHARMA (UK) LTD shared | £393,331,872 | 26 Aug 2026 | active |
| TORRENT PHARMA (UK) LTD shared | £15,529,352 | 26 Aug 2026 | active |
| UNICORN PHARMACEUTICALS LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| UNICORN PHARMACEUTICALS LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| USV UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| VANTAGE PHARMACEUTICALS LTD shared | £393,331,872 | 26 Aug 2026 | active |
| VIATRIS UK HEALTHCARE LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| VIATRIS UK HEALTHCARE LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| WAYMADE PLC shared | £393,331,872 | 26 Aug 2026 | active |
| WOCKHARDT UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| ZENTIVA PHARMA UK LIMITED shared | £393,331,872 | 26 Aug 2026 | active |
| ZENTIVA PHARMA UK LIMITED shared | £21,026,178 | 26 Aug 2026 | active |
| ZENTIVA PHARMA UK LIMITED shared | £15,529,352 | 26 Aug 2026 | active |
| ZYDUS PHARMACEUTICALS UK LTD shared | £393,331,872 | 26 Aug 2026 | active |
description
NHS National Framework for Generics Pharmaceuticals Wave 16a
Offer reference number: CM/PHG/24/5714
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:
CM/PHG/24/5714/01 Oral (plus non-parenteral) products:
CESW/LSNE/NWLN: 01/02/2027 to 31/05/2030 (40 months)
CM/PHG/24/5714/02 Hospital only products:
DLN: 01/02/2027 to 31/01/2029 (24 months)
DNW: 01/02/2027 to 31/01/2029 (24 months)
CM/PHG/24/5714/03 Hospital only (housekeeping) products:
DCE/DSW: 01/02/2027 to 30/09/2027 (8 months)
DLS/DNE: 01/02/2027 to 31/05/2028 (16 months)
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 May 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 024361-2025 |
| 24 Apr 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 037725-2026 |
| 6 May 2026 | Tender notice (UK4) | Procurement Act 2023 | 041573-2026 |
| 1 Sept 2026 | Contract award (UK6) | Procurement Act 2023 | 082784-2026 |
more from NHS England
- SANS Training 26/27 · £400,000 · 9 Sept 2026
- Discovery into the Professionalisation of the NHS DDaT Workforce · £50,000 · 8 Sept 2026
- NHS Graduate Management Training Scheme(GMTS) Engineering and Estates Management - NHSE · £825,000 · 8 Sept 2026
- Elizabeth Garrett Anderson Programme – Primary Care Manchester University · £662,000 · 7 Sept 2026
- NHS National Framework for Generics Orals, Non-Parenteral & Housekeeping · £435,634,720 · 4 Sept 2026
- NHS Regional & Local Insight · · · 4 Sept 2026
- GMTS General Management education offer - Rosalind Franklin CMI · £375,000 · 3 Sept 2026
- AHP Education Pathway Development Small and Vulnerable Professions · £80,000 · 3 Sept 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.